Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory of Diagnosis and Therapy of Lysosomal Disorders, |
RCV001376699 | SCV005089619 | likely pathogenic | Mucopolysaccharidosis, MPS-II | 2024-06-07 | criteria provided, single submitter | literature only | Prevalence of the variant significantly increased in affected individuals compared with controls (PS4_Supporting), Absent from controls (or at low frequency) in gnomAD database (PM2_Moderate), Missense change at the same amino acid residue as a pathogenic variant (PM5_Moderate), Missense variant in a gene with a low rate of benign missense variation (PP2_Supporting), Multiple lines of computational evidence support a deleterious effect (PP3_Supporting), Patient’s phenotype or family history highly specific for the disease (PP4_Moderate) |
Pediatrics, |
RCV001376699 | SCV001573791 | affects | Mucopolysaccharidosis, MPS-II | 2014-04-10 | no assertion criteria provided | research | The change c.1506G>T (p.W502C) was found to be a missense variant, where the aromatic nonpolar neutral amino acid Tryptophan at 502 position was substituted by sulfur-containing nonpolar neutral amino acid Cysteine. It was detected in a hemizygous state in one patient with attenuated phenotype from UP, India. |